Sun, 9 September 2018
This week on AI in Industry, we speak with Amir Saffari, Senior Vice President of AI at BenevolentAI, a London-based pharmaceutical company that uses machine learning to find new uses for existing drugs and new treatments for diseases.
In speaking with him, we aim to learn two things:
We hope the insights in this episode provide business leaders in the pharma industry with an understanding of the current state of AI in their space and where it might play a role in their industry in the next two to three years.
See the full interview article here: www.techemergence.com/future-drug-discovery-ai-role-man-machine